JPS5663918A - Antitumorigenic agent containing siomycin half ester - Google Patents

Antitumorigenic agent containing siomycin half ester

Info

Publication number
JPS5663918A
JPS5663918A JP14092779A JP14092779A JPS5663918A JP S5663918 A JPS5663918 A JP S5663918A JP 14092779 A JP14092779 A JP 14092779A JP 14092779 A JP14092779 A JP 14092779A JP S5663918 A JPS5663918 A JP S5663918A
Authority
JP
Japan
Prior art keywords
siomycin
half ester
antitumorigenic
agent containing
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14092779A
Other languages
Japanese (ja)
Inventor
Kenji Yamaguchi
Hiroshi Okabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP14092779A priority Critical patent/JPS5663918A/en
Publication of JPS5663918A publication Critical patent/JPS5663918A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: An antitumorigenic agent that contains a half ester form siomycin A and a dicarboxylic acid of 2W14 carbon atoms or its salt as an effective component.
CONSTITUTION: The agent includes a half ester formed from siomycin A and a 2W 14C dicarboxylic acid such as siomycin A-butanedioic half ester I, II or its pharmaceutically permissible salt such as lithium, sodium or potassium salt as an effective component. These components shown antitumorigenic activity in animals. The siomycin A-half ester is parenterally administered to a man at a dose of about 0.1W 5, preferably about 0.1W1g a day at a time or in several portions.
COPYRIGHT: (C)1981,JPO&Japio
JP14092779A 1979-10-30 1979-10-30 Antitumorigenic agent containing siomycin half ester Pending JPS5663918A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14092779A JPS5663918A (en) 1979-10-30 1979-10-30 Antitumorigenic agent containing siomycin half ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14092779A JPS5663918A (en) 1979-10-30 1979-10-30 Antitumorigenic agent containing siomycin half ester

Publications (1)

Publication Number Publication Date
JPS5663918A true JPS5663918A (en) 1981-05-30

Family

ID=15280044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14092779A Pending JPS5663918A (en) 1979-10-30 1979-10-30 Antitumorigenic agent containing siomycin half ester

Country Status (1)

Country Link
JP (1) JPS5663918A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066046A1 (en) * 2001-02-20 2002-08-29 Jonghee Kim Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066046A1 (en) * 2001-02-20 2002-08-29 Jonghee Kim Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings

Similar Documents

Publication Publication Date Title
ES485188A1 (en) Diphenylbutyl-piperzinecarboxamides
MY100359A (en) External pharmaceutical composition.
JPS542336A (en) Preventive and remedy for viral diseases
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS5663918A (en) Antitumorigenic agent containing siomycin half ester
JPS5350316A (en) Drug composition for oral administration
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
JPS5238507A (en) Detergent composition
JPS57140723A (en) Preventing composition for hyperlipemia due to neutral fat
ES8503649A1 (en) Substituted benzenesulfonic acid esters, preparation thereof and their use as medicaments.
JPS5731614A (en) Lipid improver
JPS536414A (en) Carboxylic acid aluminum salts and their preparation
JPS545948A (en) Cyclopropanecarboxylic acid esters, process for their prparation, and isecticide having low toxicity to fishees, containing the same as active constituents
JPS5238506A (en) Detergent composition
JPS54122734A (en) Antiphlogistic, analgesic agent
JPS5527152A (en) Immunizator containing 1-piperazinecarboxyamide derivative as effective ingredient
JPS54135231A (en) Cardio-vasocular medicine
JPS5426326A (en) Poultice
JPS55133316A (en) Antilipemic agent
JPS5341427A (en) Fungicidal composition for feed
JPS5498339A (en) Carcinostatic agent
JPS56145223A (en) Drug composition
JPS5473128A (en) Blood lipid depressing agent
JPS5422344A (en) Cycloprophanecarboxylic acid esters, insecticides containing the same as active agent, and their preparation
JPS5341350A (en) Stabilization of chlorine-containing resin